Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAPALENE vs ADO-TRASTUZUMAB EMTANSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADAPALENE vs ADO-TRASTUZUMAB EMTANSINE: Safety Overview

Metric ADAPALENE ADO-TRASTUZUMAB EMTANSINE
Total FAERS Reports 181,442 8,699
Deaths Reported 6 1,199
Death Rate 0.0% 13.8%
Hospitalizations 68 2,608
Average Patient Age 24.3 yrs 54.8 yrs
% Female Patients 78.5% 96.8%
FDA Approval Date Jan 14, 2022 N/A
Manufacturer Galderma Laboratories, L.P. N/A
Route TOPICAL N/A
Marketing Status Discontinued Prescription